Revance Therapeutics Announces Proposed Public Offering of Common Stock
November 02, 2015 at 06:09 AM EST
Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced a proposed underwritten public offering of 3,250,000shares of its common ...